Showing results (1381-1390 of 1,459) with videos related to
Sort By:
Pageof 146
American Journal of Respiratory and Critical Care Medicine|March 24, 2018
AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary HypertensionJiao Zhang, Jianjie Dong, Marcy Martin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B studyGuido Marcucci, Claudia D Baldus, Amy S Ruppert, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effectsSriram Pendyala, Katie Partington, Nicholas Bradley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patientsGuido Marcucci, Kati S Maharry, Klaus H Metzeler, et al.Blood Neoplasia|June 2, 2025
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trialTimothy S Pardee, Bayard L Powell, Richard A Larson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyGuido Marcucci, Kati Maharry, Yue-Zhong Wu, et al.Journal of Medicinal Chemistry|March 8, 2007
1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidateElisa A Henderson, Dagmar G Alber, Robert C Baxter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Kati Maharry, Michael D Radmacher, et al.Integrative and Comparative Biology|June 16, 2011
Respiratory plasticity in response to changes in oxygen supply and demandRyan W Bavis, Frank L Powell, Aidan Bradford, et al.Blood|October 28, 2011
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryKlaus H Metzeler, Heiko Becker, Kati Maharry, et al.Pageof 146